Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi

Condition:   Multicentric Castleman Disease Interventions:   Drug: Rituximab;   Drug: Etoposide Sponsors:   UNC Lineberger Comprehensive Cancer Center;   Fogarty International Center of the National Institute of Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials